Skip to main content

Table 1 Demographic and clinical features of admitted COVID-19 patients in Shiraz Transplant Center (N = 77)

From: COVID-19 versus applied infection control policies in a Major Transplant Center in Iran

Variable

COVID-19 PCR Positive (%) n = 21

COVID-19 PCR negative patients but highly suspicious (%)

n = 56

Age group

  < 40

3 (14.3)

7 (10.7)

 40–60

10 (47.6)

17 (28.6)

  > 60

8 (38.1)

32 (57.1)

Gender

 Male

12 (57.1)

38 (67.9)

 Female

9 (42.9)

18 (32.1)

Residence (Fars province)

 Shiraz (capital of Fars)

9 (42.9)

34 (60.7)

 Other Cities

12 (57.1)

22 (39.2)

Comorbid diseases

 Diabetes mellitus

6 (28.5)

17 (30.4)

 Cirrhosis

5 (23.8)

14 (25)

 Hypertension

4 (19.0)

18 (32.1)

 Ischemic heart disease

2 (9.5)

1 (1.8)

 Encephalopathy

1 (9.5)

5 (8.9)

 Asthma

1 (4.8)

0 (0)

 Ascites

1 (4.8)

3 (5.4)

 End-stage renal disease

1 (4.8)

7 (12.5)

 Chronic obstructive pulmonary disease

0 (0)

4 (7.1)

 Deep venous thrombosis

0 (0)

1 (1.8)

Symptoms

 Fever

11 (52.4)

17 (30.4)

 Cough

6 (28.6)

13 (23.2)

 Dyspnea

6 (28.6)

20 (35.7)

 Vomiting

5 (23.8)

8 (14.3)

 Diarrhea

3 (14.3)

6 (10.7)

 Headache

3 (14.3)

2 (3.6)

 Pharyngitis

0 (0)

0 (0)

 Rhinorrhea

0 (0)

0 (0)

 Chest pain

0 (0)

0 (0)

 Malaise

0 (0)

0 (0)

Transplantation Status

 Liver transplant

5 (23.8)

4 (7.1)

 Kidney transplant

3 (14.3)

4 (7.1)

 Candidate for transplant

8 (38.1)

15 (26.8)

Time after transplant (months)

 1–3

0 (0)

2 (25)

 3–6

2 (22.2)

2 (25)

 6–12

3 (33.3)

1 (12.5)

  > 12

4 (44.4)

3 (37.5)